Anderson R E, Chiu P, Woodbury D M
Department of Physiology, University of Utah School of Medicine, Salt Lake City 84108.
Epilepsia. 1989 Mar-Apr;30(2):208-16. doi: 10.1111/j.1528-1157.1989.tb05456.x.
The mechanism by which tolerance develops to the anticonvulsant effects of acetazolamide (AZM) was investigated in Swiss-Webster mice. The effects of single and six daily doses of 40 mg or 200 mg/kg AZM on electroshock seizure threshold (EST), maximal electroshock (MES) seizure pattern, and on the activity and total amount of carbonic anhydrase II (CAII) in various subcellular fractions (cytosol, microsomes, and myelin) of cerebral cortex, cerebellum, and brainstem were assessed. The activity of CAII was measured by microassay, and the total amount was measured by immunoassay methods developed in this laboratory. From the activity (units per microgram of protein) and total amount (nanograms per microgram protein) data, the specific activity (units per nanogram CAII) of the enzyme was calculated. With multiple doses, tolerance developed to both elevation of the EST and modification of the MES pattern noted with single doses of AZM. Accompanying the development of tolerance to the anticonvulsant effects of AZM was an increase in both the activity and specific activity of CAII in the various subcellular fractions and areas of the brain. The effects were dose dependent. Tolerance to the EST-elevating effects of AZM correlated with increases in the activity, total amount, and specific activity of CAII in the myelin fraction of the cerebral cortex.(ABSTRACT TRUNCATED AT 250 WORDS)
在瑞士韦伯斯特小鼠中研究了对乙酰唑胺(AZM)抗惊厥作用产生耐受性的机制。评估了单次及连续六天给予40mg或200mg/kg AZM对电休克惊厥阈值(EST)、最大电休克(MES)惊厥模式,以及对大脑皮层、小脑和脑干各亚细胞组分(胞质溶胶、微粒体和髓磷脂)中碳酸酐酶II(CAII)活性和总量的影响。通过微量测定法测量CAII的活性,通过本实验室开发的免疫测定法测量总量。根据活性(每微克蛋白质的单位数)和总量(每微克蛋白质的纳克数)数据,计算该酶的比活性(每纳克CAII的单位数)。多次给药后,对单次给药AZM引起的EST升高和MES模式改变均产生了耐受性。伴随着对AZM抗惊厥作用耐受性的产生,大脑各亚细胞组分和区域中CAII的活性和比活性均增加。这些作用具有剂量依赖性。对AZM升高EST作用的耐受性与大脑皮层髓磷脂组分中CAII的活性、总量和比活性增加相关。(摘要截短于250字)